CardioBrief: Slow Down Urged on SPRINT
The 25% reduction in relative risk seen in patients treated to 120 vs 140 mm Hg corresponds to an absolute risk reduction of 1.6%.
New Analyses Only Partly Defuse ROCKET-AF Trial Concerns
Critics continue to call for independent analysis by outside investigators not involved with the original trial.
Statin Intolerance Test Faces Skeptics
Even experts involved in clinical trials of the at-home saliva test say it has no place in routine clinical practice.
